Anti-PADI3 / PAD3 antibody - N-terminal (ab183209)
Key features and details
- Rabbit polyclonal to PADI3 / PAD3 - N-terminal
- Suitable for: ELISA, IHC-P, IP, ICC/IF, WB
- Reacts with: Human
- Isotype: IgG
Get better batch-to-batch reproducibility with a recombinant antibody
- Research with confidence – consistent and reproducible results with every batch
- Long-term and scalable supply – powered by recombinant technology for fast production
- Success from the first experiment – confirmed specificity through extensive validation
- Ethical standards compliant – production is animal-free
Overview
-
Product name
Anti-PADI3 / PAD3 antibody - N-terminal
See all PADI3 / PAD3 primary antibodies -
Description
Rabbit polyclonal to PADI3 / PAD3 - N-terminal -
Host species
Rabbit -
Specificity
Reacts with 75 kDa PADI3 protein. No cross reaction with the other isoforms. -
Tested applications
Suitable for: ELISA, IHC-P, IP, ICC/IF, WBmore details -
Species reactivity
Reacts with: Human
Predicted to work with: Mouse, Rat -
Immunogen
Synthetic peptide corresponding to Human PADI3/ PAD3 (N terminal). 15 residues.
Database link: Q9ULW8 -
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
Constituents: 2% Sucrose, 1.21% Tris, 0.75% Glycine -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab183209 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ELISA |
Use at an assay dependent concentration.
|
|
IHC-P |
Use at an assay dependent concentration.
|
|
IP |
Use at an assay dependent concentration.
|
|
ICC/IF |
Use at an assay dependent concentration.
|
|
WB | (1) |
Use at an assay dependent concentration.
|
Notes |
---|
ELISA
Use at an assay dependent concentration. |
IHC-P
Use at an assay dependent concentration. |
IP
Use at an assay dependent concentration. |
ICC/IF
Use at an assay dependent concentration. |
WB
Use at an assay dependent concentration. |
Target
-
Function
Catalyzes the deimination of arginine residues of proteins. -
Tissue specificity
Hair follicles, and epidermis at very low levels. -
Sequence similarities
Belongs to the protein arginine deiminase family. -
Cellular localization
Cytoplasm. - Information by UniProt
-
Database links
- Entrez Gene: 51702 Human
- Entrez Gene: 18601 Mouse
- Entrez Gene: 29520 Rat
- Omim: 606755 Human
- SwissProt: Q9ULW8 Human
- SwissProt: Q9Z184 Mouse
- SwissProt: P70708 Rat
- Unigene: 149195 Human
see all -
Alternative names
- PADI3 antibody
- PADI3_HUMAN antibody
- PDI3 antibody
see all
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (3)
ab183209 has been referenced in 3 publications.
- Casanova V et al. Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection. Front Immunol 11:85 (2020). PubMed: 32117246
- Chen LY et al. Palmitoyl Acyltransferase Activity of ZDHHC13 Regulates Skin Barrier Development Partly by Controlling PADi3 and TGM1 Protein Stability. J Invest Dermatol 140:959-970.e3 (2020). PubMed: 31669413
- Turunen S et al. Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue. Arthritis Res Ther 18:239 (2016). IHC-P ; Human . PubMed: 27765067